CALR and myeloproliferative disorder: Based on the unique clinical aspects of mutant CRT‐mediated MPNs and the distinct interactions that trigger cell transformation, a better understanding of the role of mutated CRT in the pathogenesis of MPNs could lead to new diagnostics and treatments for MPN patients with CALR mutations.